Channel Therapeutics (CHRO) Announces Reverse Share Split, $50.1M Private Placement
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall Street dips as higher yields, rising oil prices mark shaky start to SeptemberÂ
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
- The Warsh pivot markets didn't expect
Channel Therapeutics Announces Reverse Common Stock Split in Conjunction with the Close of the Merger with Pelthos Therapeutics and Concurrent $50.1 Million Private Placement
June 27, 2025 9:15 AM EDTFREEHOLD, N.J., June 27, 2025 (GLOBE NEWSWIRE) -- Channel Therapeutics Corporation, (Channel or the Company), (NYSE American: CHRO), an emerging leader in the development of non-opioid pain treatment therapeutics, today announced a 10-for-one reverse split (the Reverse Stock Split) of the Companys common stock (the Common Stock). The Reverse Stock Split is intended to increase the market price per share of the Companys Common Stock and help the Company satisfy the initial listing requirements of the NYSE American (the NYSE American) in connection with the anticipated closing of the previously announced merger of CHRO... More
